BRAIN Biotech AG
BNN
Rank in Stocks
#21677
Headquartered in Zwingenberg, Germany, and founded in 1993, BRAIN Biotech AG... Headquartered in Zwingenberg, Germany, and founded in 1993, BRAIN Biotech AG (renamed from B.R.A.I.N. Biotechnology Research and Information Network AG in April 2021) specializes in the discovery, development, production, and commercialization of advanced biological solutions. These include enzymes, biocatalysts, microorganisms, and naturally derived active compounds, catering to the chemical industry across Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two distinct segments: BioScience and BioIndustrial. The BioScience division is dedicated to uncovering and developing bioactive natural ingredients, such as sugar alternatives, taste modifiers, and other nature-based active components for diverse applications in the food, animal nutrition, skincare, cosmetics, and broader chemical sectors. Concurrently, the BioIndustrial segment focuses on identifying and optimizing enzymes and biocatalysts critical for manufacturing food and beverages, medical wound care products, lubricants, as well as for starch processing and bioethanol production. This segment also engineers microorganisms to serve as functional biomass for optimizing industrial manufacturing processes, converting greenhouse gas CO2 into a valuable industrial raw material, and facilitating the extraction of precious and rare earth metals. Furthermore, BRAIN Biotech AG has established strategic alliances with AnalytiCon Discovery GmbH and Roquette to jointly develop natural sweeteners and enhanced sweet taste solutions.
Share Price
$2.94
Last synced: 2026-11-09
Market Cap
$64.24M
Change (1 day)
0.67%
Change (1 year)
7.09%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BRAIN Biotech AG (BNN)
Category
Healthcare
Operating Margin for BRAIN Biotech AG (BNN)
Operating Margin as of November 2026 TTM: -16.69%
According to BRAIN Biotech AG's latest financial reports, its current operating margin (TTM) is -16.69%. At the end of 2025 the company had an operating margin of -17.15%.
Operating Margin history for BRAIN Biotech AG from 2012 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -16.69% | -2.68% |
| 2025 | -17.15% | 5.86% |
| 2024 | -16.20% | 33.44% |
| 2023 | -12.14% | -20.13% |
| 2022 | -15.20% | -10.90% |
| 2021 | -17.06% | -26.50% |
| 2020 | -23.21% | 58.32% |
| 2019 | -14.66% | -60.51% |
| 2018 | -37.12% | -4.55% |
| 2017 | -38.89% | -35.83% |
| 2016 | -60.60% | 180.04% |
| 2015 | -21.64% | -43.16% |
| 2014 | -38.07% | -12.08% |
| 2013 | -43.30% | -42.91% |
| 2012 | -75.84% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -102.31% |
US
|
|
| -149.01% | -91.07% |
US
|
|
| 25.57% | -101.53% |
AU
|
|
| 31.23% | -101.87% |
BE
|
|
| 29.35% | -101.76% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about BRAIN Biotech AG's operating margin
What is BRAIN Biotech AG's operating margin?
BRAIN Biotech AG's operating margin is -16.69%, as of Nov 2026.
What was BRAIN Biotech AG's operating margin in 2025?
In 2025, BRAIN Biotech AG's operating margin was -17.15%, compared with -16.20% in 2024.
How has BRAIN Biotech AG's operating margin changed since 2020?
From 2020 to 2025, BRAIN Biotech AG's operating margin was highest in 2023 (-12.14%) and lowest in 2020 (-23.21%).
How does BRAIN Biotech AG's operating margin compare with similar companies?
BRAIN Biotech AG's operating margin (-16.69%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.